SCR-LIP-000382 · Claim · machine-readable JSON →
MR lymphangiography with intracutaneous gadoteridol distinguished pure lipedema from lipo-lymphedema: epifascial high-signal edema on T2-TSE was present in 100% (16/16) of lipo-lymphedema limbs but 0% (0/10) of pure lipedema limbs, while subcutaneous fat was thickened in all 26 limbs; contrast peak in lower-leg lymphatics was delayed in lipo-lymphedema (peak 45–55 min) versus lipedema (peak 35 min), and 60% of pure lipedema limbs showed subclinical dilated lymphatics despite no T2 lymphedema signal.
Claim at a glance
- Type
- clinical association
- Knowledge state
- Emerging
- Evidence certainty
- low (GRADE)
- Evidence
- 1 source(s)
- Answers
- 3 question(s)
- Dates
- 2026-05-31 → 2026-05-31
Structured evidence, machine-compiled — not a verdict.
Auto-compiled by the Layer 1 surveillance loop; not yet human-reviewed. anthropic/claude-opus-4.8 · 2026-05-31
Evidence over time
Evidence (1)
- MR imaging of the lymphatic system in patients with lipedema and lipo-lymphedema — Lohrmann et al. (2009) ✓ verified — consistent · case series · 2009 · reading confidence: high
“LIPEDEMA PURO: 0/10 (0%) com sinal de linfedema na T2-TSE — derme e hipoderme normais à T2”
The study directly evaluates MR lymphangiography to distinguish lipedema from lipo-lymphedema, reporting specific imaging findings, signal differences, and lymphatic flow timing that differentiate the conditions, directly bearing on the que
Context (PECO)
Answers these questions
- Can MRI, lymphoscintigraphy, or DXA differentiate lipedema from lymphedema and other fat distributions? consistent
- Can MRI differentiate lipedema from lymphedema and other fat distributions? consistent
- Can lymphoscintigraphy differentiate lipedema from lymphedema? consistent
Gaps & caveats
Auto-ingested single source; not yet human-reviewed.
Change log
- 2026-05-31 — created · auto-ingested for SQ-LIP-000023